Animal Drug User Fee Act: Public Meeting and Request for Comments
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This notice announces a virtual public meeting to discuss the Animal Drug User Fee Act (ADUFA) and invites public comments on the program and its reauthorization. Stakeholders in the animal drug industry are encouraged to participate and share their views on potential improvements or changes before the current authorization expires in 2028.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Public meeting scheduled to discuss ADUFA's future
- Invitation to provide comments on program reauthorization
- FDA seeks input on potential changes to enhance ADUFA
Obligations
What this law requires
The FDA must hold a public meeting to gather public input on the reauthorization of the Animal Drug User Fee Act.
Stakeholders in the animal drug industry must register to attend the public meeting by emailing their complete contact information by May 22, 2026.
The FDA must publish comments received on its website following the public meeting.
Individuals wishing to make an oral presentation must submit their request during registration by May 1, 2026.
Members of the public interested in attending the public meeting must register by May 22, 2026.